RHBDL1
geneOn this page
Also known as RRP
Summary
RHBDL1 (rhomboid like 1, HGNC:10007) is a protein-coding gene on chromosome 16p13.3, encoding Rhomboid-related protein 1 (O75783). May be involved in regulated intramembrane proteolysis and the subsequent release of functional polypeptides from their membrane anchors.
This gene encodes a protein similar to Rhomboid in Drosophila which is involved in signalling in the Spitz/epidermal growth factor receptor/mitogen-activated protein kinase pathway. The Rhomboid family of proteins consists of intramembrane serine proteases containing several transmembrane domains. Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 9028 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001278720
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10007 |
| Approved symbol | RHBDL1 |
| Name | rhomboid like 1 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RRP |
| Ensembl gene | ENSG00000103269 |
| Ensembl biotype | protein_coding |
| OMIM | 603264 |
| Entrez | 9028 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 9 protein_coding, 1 retained_intron
ENST00000219551, ENST00000352681, ENST00000450775, ENST00000561556, ENST00000897891, ENST00000897892, ENST00000897893, ENST00000943440, ENST00000943441, ENST00000943442
RefSeq mRNA: 3 — MANE Select: NM_001278720
NM_001278720, NM_001278721, NM_001318733
CCDS: CCDS10418, CCDS61779
Canonical transcript exons
ENST00000352681 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000664215 | 677639 | 677699 |
| ENSE00000664216 | 677459 | 677559 |
| ENSE00000873924 | 677781 | 678268 |
| ENSE00001387178 | 675671 | 675829 |
| ENSE00003555778 | 676971 | 677119 |
| ENSE00003595717 | 676672 | 676896 |
| ENSE00003682028 | 677276 | 677388 |
| ENSE00003684796 | 676336 | 676497 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 95.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4348 / max 19.0024, expressed in 170 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 151966 | 0.4348 | 170 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 95.18 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.24 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.97 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.90 | gold quality |
| cerebellum | UBERON:0002037 | 90.86 | gold quality |
| cingulate cortex | UBERON:0003027 | 87.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.70 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.89 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.81 | gold quality |
| amygdala | UBERON:0001876 | 83.67 | gold quality |
| frontal cortex | UBERON:0001870 | 82.50 | gold quality |
| neocortex | UBERON:0001950 | 82.23 | gold quality |
| nucleus accumbens | UBERON:0001882 | 81.99 | gold quality |
| caudate nucleus | UBERON:0001873 | 79.95 | gold quality |
| hypothalamus | UBERON:0001898 | 79.64 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.43 | gold quality |
| cerebral cortex | UBERON:0000956 | 78.87 | gold quality |
| putamen | UBERON:0001874 | 78.80 | gold quality |
| brain | UBERON:0000955 | 78.16 | gold quality |
| telencephalon | UBERON:0001893 | 78.01 | gold quality |
| pituitary gland | UBERON:0000007 | 77.99 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.96 | gold quality |
| central nervous system | UBERON:0001017 | 77.95 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 77.84 | silver quality |
| forebrain | UBERON:0001890 | 77.78 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.99 | gold quality |
| apex of heart | UBERON:0002098 | 76.21 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.91 | gold quality |
| right adrenal gland | UBERON:0001233 | 75.75 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 11.72 |
| E-MTAB-6058 | no | 16.70 |
| E-ANND-3 | no | 2.72 |
Regulation
Is transcription factor: no
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rhbdl1 | ENSDARG00000087040 |
| mus_musculus | Rhbdl1 | ENSMUSG00000025735 |
| rattus_norvegicus | Rhbdl1 | ENSRNOG00000019921 |
| drosophila_melanogaster | rho-5 | FBGN0041723 |
| caenorhabditis_elegans | WBGENE00004402 | |
| caenorhabditis_elegans | WBGENE00004403 |
Paralogs (5): RHBDF1 (ENSG00000007384), RHBDF2 (ENSG00000129667), RHBDL3 (ENSG00000141314), RHBDL2 (ENSG00000158315), PARL (ENSG00000175193)
Protein
Protein identifiers
Rhomboid-related protein 1 — O75783 (reviewed: O75783)
Alternative names: Rhomboid-like protein 1
All UniProt accessions (2): O75783, H3BQ51
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in regulated intramembrane proteolysis and the subsequent release of functional polypeptides from their membrane anchors.
Subcellular location. Membrane.
Tissue specificity. Detected in heart, brain, skeletal muscle and kidney.
Similarity. Belongs to the peptidase S54 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75783-1 | 1 | yes |
| O75783-2 | 2 |
RefSeq proteins (3): NP_001265649, NP_001265650, NP_001305662 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR022764 | Peptidase_S54_rhomboid_dom | Domain |
| IPR035952 | Rhomboid-like_sf | Homologous_superfamily |
| IPR051739 | Rhomboid_IM_Serine_Proteases | Family |
Pfam: PF01694
UniProt features (13 total): transmembrane region 7, active site 2, chain 1, splice variant 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75783-F1 | 72.85 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 312 (nucleophile); 377
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
MODULE_64, MODULE_66, SMID_BREAST_CANCER_LUMINAL_B_UP, MODULE_88, MODULE_11, MODULE_60, MODULE_104, CTGAGCC_MIR24, MODULE_55, GOBP_PROTEOLYSIS, NIKOLSKY_BREAST_CANCER_16P13_AMPLICON, MODULE_13, GOMF_PEPTIDASE_ACTIVITY, MORF_TNFRSF25, MODULE_23
GO Biological Process (2): proteolysis (GO:0006508), signal transduction (GO:0007165)
GO Molecular Function (5): serine-type endopeptidase activity (GO:0004252), protein binding (GO:0005515), peptidase activity (GO:0008233), serine-type peptidase activity (GO:0008236), hydrolase activity (GO:0016787)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| binding | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| serine hydrolase activity | 1 |
| catalytic activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
794 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RHBDL1 | RHBDD1 | Q8TEB9 | 724 |
| RHBDL1 | A0A1W2PP11 | A0A1W2PP11 | 687 |
| RHBDL1 | PARL | Q9H300 | 687 |
| RHBDL1 | RHBDF1 | Q96CC6 | 621 |
| RHBDL1 | RHBDF2 | Q6PJF5 | 596 |
| RHBDL1 | RHBDD2 | Q6NTF9 | 587 |
| RHBDL1 | RHBDD3 | Q9Y3P4 | 556 |
| RHBDL1 | UBAC2 | Q8NBM4 | 485 |
| RHBDL1 | EGFR | P00533 | 474 |
| RHBDL1 | TTLL2 | Q9BWV7 | 469 |
| RHBDL1 | OR10S1 | Q8NGN2 | 434 |
| RHBDL1 | TTLL3 | Q9Y4R7 | 423 |
| RHBDL1 | WDR90 | Q96KV7 | 422 |
| RHBDL1 | CLEC14A | Q86T13 | 415 |
| RHBDL1 | TM7SF2 | O76062 | 402 |
IntAct
39 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RHBDL1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | VAC14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TUSC5 | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | ARLN | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | SPTSSA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | ABHD16A | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | COMT | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | FXYD6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | APOD | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | MFF | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | ITGB8 | psi-mi:“MI:0914”(association) | 0.530 |
| RHBDL1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RHBDL1 | KRTAP6-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RHBDL1 | VAC14 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TUSC5 | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| APOD | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARLN | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RHBDL1 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPTSSA | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ABHD16A | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| COMT | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FXYD6 | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MFF | RHBDL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (24): MAGI3 (Affinity Capture-MS), DLG3 (Affinity Capture-MS), HERC3 (Affinity Capture-MS), MAGI3 (Affinity Capture-MS), DLG3 (Affinity Capture-MS), MAGI2 (Affinity Capture-MS), ITGB8 (Affinity Capture-MS), RHBDL1 (Two-hybrid), RHBDL1 (Two-hybrid), FXYD6 (Two-hybrid), C4orf3 (Two-hybrid), SPTSSA (Two-hybrid), MFF (Two-hybrid), TUSC5 (Two-hybrid), KRTAP10-8 (Two-hybrid)
ESM2 similar proteins: A0JP80, A1A5Z0, A5D6W6, A7YWN2, B2MVP8, B6CZ46, L5KLU7, O42153, O75783, O75908, O77759, O88908, P58872, P58873, P86243, Q1HG44, Q1KZG0, Q1XHX8, Q32LM8, Q49LS7, Q52KL1, Q5CZN0, Q5KR61, Q5T197, Q5TM67, Q5XIL6, Q6AX73, Q6AZ83, Q6MG14, Q6NSQ9, Q6P5W5, Q767L9, Q7TNJ2, Q7TQM4, Q80YU0, Q86VD9, Q8AVI9, Q8CIP5, Q8IWX5, Q8IXM6
Diamond homologs: A2AGA4, A4WFK8, F4JBM4, O75783, O82756, O88779, P20350, P34356, P58872, P58873, Q0WQX7, Q19821, Q8VC82, Q8VZ48, Q9CAN1, Q9LYP1, Q9NX52, P54493, Q9SSR0, A0JPA1, A1AGU7, A7MGE5, A7ZSV4, A8A5N2, A9L8T6, A9MMA7, B0VX73, B1IP42, B1LI84, B1MT31, B1X769, B2U3N2, B5BHH5, B5YTX6, B6I2Y7, B7L4V0, B7LSC6, B7M2I4, B7MDQ0, B7N156
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1383 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:676965:CCCCA:C | acceptor_loss | 1.0000 |
| 16:676966:CCCAG:C | acceptor_loss | 1.0000 |
| 16:676967:CCA:C | acceptor_loss | 1.0000 |
| 16:676968:CAGAT:C | acceptor_loss | 1.0000 |
| 16:676969:A:AG | acceptor_gain | 1.0000 |
| 16:676970:G:GA | acceptor_loss | 1.0000 |
| 16:676970:G:GG | acceptor_gain | 1.0000 |
| 16:676970:GATC:G | acceptor_gain | 1.0000 |
| 16:676991:C:CA | acceptor_gain | 1.0000 |
| 16:676992:G:A | acceptor_gain | 1.0000 |
| 16:677115:GTTGG:G | donor_gain | 1.0000 |
| 16:677116:TTGG:T | donor_gain | 1.0000 |
| 16:677117:TGG:T | donor_gain | 1.0000 |
| 16:677118:GG:G | donor_gain | 1.0000 |
| 16:677118:GGG:G | donor_gain | 1.0000 |
| 16:677119:GG:G | donor_gain | 1.0000 |
| 16:677119:GGTG:G | donor_loss | 1.0000 |
| 16:677120:G:GG | donor_gain | 1.0000 |
| 16:677121:T:G | donor_loss | 1.0000 |
| 16:677123:AGTAG:A | donor_loss | 1.0000 |
| 16:677259:T:TA | acceptor_gain | 1.0000 |
| 16:677267:T:A | acceptor_gain | 1.0000 |
| 16:677269:T:TA | acceptor_gain | 1.0000 |
| 16:677270:G:A | acceptor_gain | 1.0000 |
| 16:677274:A:AG | acceptor_gain | 1.0000 |
| 16:677274:AG:A | acceptor_gain | 1.0000 |
| 16:677274:AGGCT:A | acceptor_gain | 1.0000 |
| 16:677275:G:A | acceptor_loss | 1.0000 |
| 16:677275:G:GT | acceptor_gain | 1.0000 |
| 16:677275:GG:G | acceptor_gain | 1.0000 |
AlphaMissense
2406 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:676980:T:C | F211L | 0.999 |
| 16:676982:C:A | F211L | 0.999 |
| 16:676982:C:G | F211L | 0.999 |
| 16:677320:G:A | G272E | 0.999 |
| 16:677515:G:T | G314W | 0.999 |
| 16:677525:C:A | A317D | 0.999 |
| 16:677543:T:C | L323P | 0.999 |
| 16:677783:A:C | S350R | 0.999 |
| 16:677785:C:A | S350R | 0.999 |
| 16:677785:C:G | S350R | 0.999 |
| 16:677795:G:C | G354R | 0.999 |
| 16:677796:G:A | G354D | 0.999 |
| 16:677852:A:C | S373R | 0.999 |
| 16:677854:C:A | S373R | 0.999 |
| 16:677854:C:G | S373R | 0.999 |
| 16:677874:G:A | G380D | 0.999 |
| 16:677885:G:A | G384R | 0.999 |
| 16:677885:G:C | G384R | 0.999 |
| 16:677885:G:T | G384W | 0.999 |
| 16:677886:G:A | G384E | 0.999 |
| 16:677891:A:C | S386R | 0.999 |
| 16:677893:C:A | S386R | 0.999 |
| 16:677893:C:G | S386R | 0.999 |
| 16:677897:G:C | G388R | 0.999 |
| 16:677058:T:G | Y237D | 0.998 |
| 16:677329:T:C | L275P | 0.998 |
| 16:677376:G:C | G291R | 0.998 |
| 16:677377:G:A | G291D | 0.998 |
| 16:677465:T:C | L297P | 0.998 |
| 16:677503:G:A | G310R | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000019896 (16:675919 G>A), RS1000246681 (16:675286 C>T), RS1000456455 (16:675529 G>T), RS1001041769 (16:674739 C>T), RS1001430399 (16:674854 A>G), RS1001490677 (16:675292 G>A,C,T), RS1002185589 (16:676074 T>C,G), RS1002391688 (16:678756 G>A), RS1002496699 (16:674496 C>G,T), RS1002829648 (16:678503 G>A,T), RS1002952596 (16:678228 T>A), RS1003122039 (16:674601 G>A), RS1003803520 (16:677828 C>A), RS1004170281 (16:674127 T>C), RS1004333114 (16:678325 G>A)
Disease associations
OMIM: gene MIM:603264 | disease phenotypes: MIM:618093
GenCC curated gene-disease
Mondo (1): spinocerebellar ataxia 48 (MONDO:0032526)
Orphanet (1): Spinocerebellar ataxia type 48 (Orphanet:631103)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_12 | Body mass index | 5.000000e-11 |
| GCST010796_5294 | Electrocardiogram morphology (amplitude at temporal datapoints) | 9.000000e-09 |
| GCST010796_5295 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-08 |
| GCST010796_5296 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_5297 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Lead | affects expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | increases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spinocerebellar ataxia 48